Genetics

Mycotoxins

The Role of Gene Analysis in Treating Chronic Illness

Mycotoxin - June 2021

<h6>Eric Gordon, M.D.</h6>
Welcome. To another edition of &#8220;Mycotoxins and Chronic Illness.&#8221; Today, it&#8217;s just exciting and a pleasure to be interviewing Sharon Houseman-Cohen, who has many attributes. So right now, She is the Medical Director and Co-founder of IntellxxDNA. Her background is, she has a Master&#8217;s in Cell and Cell Development and Developmental Biology, and she&#8217;s a M.D., a graduate from Harvard Medical School. And as I think I mentioned the other day, one of the hallmarks of most of the doctors that I&#8217;ve interviewed is that they had training in usually a master&#8217;s level in an element of science before they went to medical school. So, they learned to think scientifically because unfortunately, many doctors start off they desire to be a scientist, but we were trained after a while to just be expert at pattern recognition, and that&#8217;s good.
But if you don&#8217;t think, and you just recognize patterns and you only have five minutes to interview the patient, those of you with chronic illness have seen the results. You&#8217;re constantly frustrated, okay. &#8216;Cause people aren&#8217;t listening to your whole story and they&#8217;re not finding the parts that don&#8217;t fit. And what Sharon has done for us, is created a tool that allows physicians and patients to begin to see where they fit in the world. To find out their own special individual characteristics and why, and often not just why, but what we can do about why, that they are and you are in the position of having a chronic illness. So, but she&#8217;s done this to the use of genetics. And first of all, I&#8217;m gonna start off and just give us a little overview of how genomics has come to play such a big role in your career.

https://drsummits.s3.us-west-1.amazonaws.com/2021+Summits/Mycotoxins+and+Chronic+Illness+Summit/Transcripts/Dr.+Sharon+Hausman-Cohen+Transcript+File.pdf

Dr. Sharon Hausman-Cohen is the Chief Medical Officer and co-founder of IntellxxDNA and Resilient Health Austin. Dr. Hausman-Cohen has been in the field of integrative medicine for over 25 years. She and her co-founder developed IntellxxDNA as an answer to an unmet need in the integrative and functional medicine community; the need for an accurate, evidence-based genomics tool geared at helping functional and integrative physicians practice personalized medicine. They envisioned and created a tool that could help identify root causes of cognitive decline, environmentally acquired illness and other chronic illnesses, and one that could also help clinicians know how to address these genomic factors with lifestyle, diet, supplementation and occasionally medications. The IntellxxDNA™ clinical decision support tool is now being used as an integral part of medical decision making by Integrative and Functional Medicine clinicians  across the country. IntellxxDNA is also the genomics used in the study that is currently pending publication done by Dr. Bredesen and colleagues.

Dr. Sharon Hausman-Cohen

Sharon Hausman-Cohen

Eric Gordon, MD is President of Gordon Medical Research Center and clinical director of Gordon Medical Associates which specializes in complex chronic illness. In addition to being in clinical practice for over 40 years, Dr. Gordon is engaged in clinical research focused on bringing together leading international medical researchers and cutting-edge clinicians. His research is focusing on ME/CFS, Lyme disease, autoimmune diseases, and autism.

The Role of Gene Analysis in Treating Chronic Illness

Eric Gordon, MD

Sharon Hausman-Cohen

Summary

Content Provided By

Eric Gordon, MD

Guest Experts

Sharon Hausman-Cohen